Cover Image
Market Research Report
Product code 
1072085

U.S. Remote Patient Monitoring Market - Industry Outlook & Forecast 2022-2027

Published: | Arizton Advisory & Intelligence | 194 Pages | Delivery time: 1-2 business days

Price

Back to Top
U.S. Remote Patient Monitoring Market - Industry Outlook & Forecast 2022-2027
Published: April 28, 2022
Arizton Advisory & Intelligence
Content info: 194 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Arizton's report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

The US remote patient monitoring market is expected to grow at a CAGR of 12.63%.

MARKET GROWTH ENABLERS

  • Increasing Innovations in Wearable Medical Devices
  • Growing Use of Mobile Technologies & Smart Devices for Remote Patient Monitoring
  • Aging Population Vulnerable to Chronic Diseases

U.S. REMOTE PATIENT MONITORING MARKET SEGMENTATION

The Devices and Software segment accounts for the largest share than that of the Services segment in the U.S. remote patient monitoring market. The increasing adoption of wearable medical devices, technological advancements in IoT, the rise in the adoption of home healthcare systems are expected to boost the adoption of device & software segment in the remote patient monitoring market.

The hospitals and specialty clinics accounted for the largest share in the U.S. remote patient monitoring market and the Homecare setting is anticipated to be the fastest-growing end-user. With the increased demand for hospital beds and the challenge of delivering care with staff shortages, some health care centers prefer remote patient monitoring solutions. Moreover, technological advancements have made it viable to monitor patients remotely while at home or in skilled nursing facilities.

Segmentation by Component

  • Devices & Software
  • Services

Segmentation by Devices

  • Cardiac Monitoring Devices
  • Respiratory Monitoring Devices
  • Blood Glucose Monitors (Includes CGM)
  • Fetal & Neonatal Monitoring Devices
  • Other Rpm Devices

Segmentation by Application

  • Cardiology Remote Patient Monitoring
  • Pulmonology Remote Patient Monitoring
  • Endocrinology Remote Patient Monitoring*
  • Others

Segmentation by End-User

  • Hospitals & Specialty Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Long Term & Acute Care Centers
  • Other End Users

COMPETITIVE LANDSCAPE

Manufacturers and providers are rapidly approaching the RPM technology to limit costs, improve patient outcomes, and cut down on using more expensive services for a share of this growing market.

The major competitors in the industry are focusing their efforts on reducing the size of remote patient monitoring devices. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other industry participants. As a result, these factors are expected to increase the remote patient monitoring market size.

Key Vendors

  • Medtronic
  • Philips Healthcare
  • ResMed

Other Prominent Vendors

  • 100-Plus
  • A&D Company
  • Abbott
  • AltumView Syste
  • BIOTRONIK
  • Boston Scientific
  • Bardy Diagnostics
  • Cardiomo Care
  • Cardiologs
  • Dragerwerk
  • Hoffmann-La Roche
  • GE Healthcare
  • GrandCare Systems
  • Honeywell International
  • iHealthUnifiedcare
  • Qardio
  • MedM
  • Masimo Corporation
  • Medopad
  • Nihon Kohden
  • Omron Healthcare
  • OSPLabs
  • Resideo Technologies
  • Smiths Medical
  • Spacelabs Healthcare
  • Senseonics
  • TeleMedCare
  • VitalConnect
  • Vitls
  • Modivcare
  • Hill-Rom
  • Vivify Health
  • ACL Digital
  • Dexcom
  • iRhythm Technologies
  • Vivalink
  • Biobeat
  • CareValidate
  • Biofourmis
  • CAREMINDr
  • Datos Health
Product Code: ARZ220321

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY COMPONENT
    • 4.3.2 MARKET SEGMENTATION BY APPLICATION
    • 4.3.3 MARKET SEGMENTATION BY END-USER
    • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY, & REMOTE MONITORING
  • 8.2 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING
  • 8.3 INCREASING ROLE OF INTERNET OF THINGS (IOT) IN REMOTE MONITORING & HEALTHCARE

9 MARKET GROWTH ENABLERS

  • 9.1 INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES
  • 9.2 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING
  • 9.3 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
  • 9.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

10 MARKET GROWTH RESTRAINTS

  • 10.1 REGULATORY VARIATIONS ACROSS COUNTRY
  • 10.2 LACK OF DATA ACCURACY

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
    • 11.2.1 MARKET SHARE BY COMPONENT
    • 11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
    • 11.2.3 MARKET SHARE BY APPLICATION
    • 11.2.4 MARKET SHARE BY END-USER
  • 11.3 FIVE FORCES ANALYSIS
    • 11.3.1 THREAT OF NEW ENTRANTS
    • 11.3.2 BARGAINING POWER OF SUPPLIERS
    • 11.3.3 BARGAINING POWER OF BUYERS
    • 11.3.4 THREAT OF SUBSTITUTES
    • 11.3.5 COMPETITIVE RIVALRY

12 COMPONENT

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE

13 DEVICES & SOFTWARE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
    • 13.2.1 MARKET SIZE & FORECAST
  • 13.3 CARDIAC MONITORING DEVICES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 ELECTROCARDIOGRAPHS (ECGS): MARKET OVERVIEW
    • 13.3.4 MARKET SIZE & FORECAST
    • 13.3.5 CARDIAC MONITORS: MARKET OVERVIEW
    • 13.3.6 MARKET SIZE & FORECAST
    • 13.3.7 BLOOD PRESSURE MONITORS: MARKET OVERVIEW
    • 13.3.8 MARKET SIZE & FORECAST
    • 13.3.9 OTHERS: MARKET OVERVIEW
    • 13.3.10 MARKET SIZE & FORECAST
  • 13.4 RESPIRATORY MONITORING DEVICES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 APNEA MONITORS: MARKET OVERVIEW
    • 13.4.4 MARKET SIZE & FORECAST
    • 13.4.5 PULSE OXIMETERS: MARKET OVERVIEW
    • 13.4.6 MARKET SIZE & FORECAST
    • 13.4.7 OTHER RESPIRATORY MONITORING DEVICES: MARKET OVERVIEW
    • 13.4.8 MARKET SIZE & FORECAST
  • 13.5 BLOOD GLUCOSE MONITORS
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
  • 13.6 FETAL & NEONATAL MONITORING DEVICES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
  • 13.7 OTHER RPM DEVICES
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST

14 SERVICES

  • 14.1 MARKET OVERVIEW
  • 14.2 MARKET SIZE & FORECAST

15 APPLICATION

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 CARDIOLOGY
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
  • 15.4 PULMONOLOGY
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
  • 15.5 ENDOCRINOLOGY
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
  • 15.6 OTHERS
    • 15.6.1 MARKET OVERVIEW
    • 15.6.2 MARKET SIZE & FORECAST

16 END-USER

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 HOSPITALS & SPECIALTY CLINICS
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
  • 16.4 HOMECARE SETTINGS
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 AMBULATORY SURGICAL CENTERS
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 LONG-TERM & ACUTE CARE CENTERS
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
  • 16.7 OTHERS
    • 16.7.1 MARKET OVERVIEW
    • 16.7.2 MARKET SIZE & FORECAST

17 COMPETITIVE LANDSCAPE

  • 17.1 COMPETITION OVERVIEW BY DEVICES & SOFTWARE
    • 17.1.1 MEDTRONIC
    • 17.1.2 PHILIPS HEALTHCARE
    • 17.1.3 RESMED
  • 17.2 COMPETITION OVERVIEW BY SERVICES
    • 17.2.1 MEDM
    • 17.2.2 IHEALTHUNIFIEDCARE
    • 17.2.3 QARDIO

18 KEY VENDORS

  • 18.1 MEDTRONIC
    • 18.1.1 BUSINESS OVERVIEW
    • 18.1.2 PRODUCT OFFERING
  • 18.2 PHILIPS HEALTHCARE
    • 18.2.1 BUSINESS OVERVIEW
    • 18.2.2 PRODUCT OFFERING
  • 18.3 RESMED
    • 18.3.1 BUSINESS OVERVIEW
    • 18.3.2 PRODUCT OFFERING

19 OTHER PROMINENT VENDORS

  • 19.1 100-PLUS
    • 19.1.1 BUSINESS OVERVIEW
    • 19.1.2 PRODUCT OFFERINGS
  • 19.2 A&D COMPANY
    • 19.2.1 BUSINESS OVERVIEW
    • 19.2.2 PRODUCT OFFERINGS
  • 19.3 ABBOTT
    • 19.3.1 BUSINESS OVERVIEW
    • 19.3.2 PRODUCT OFFERINGS
  • 19.4 ALTUMVIEW SYSTEMS
    • 19.4.1 BUSINESS OVERVIEW
    • 19.4.2 PRODUCT OFFERINGS
  • 19.5 BIOTRONIK
    • 19.5.1 BUSINESS OVERVIEW
    • 19.5.2 PRODUCT OFFERING
  • 19.6 BOSTON SCIENTIFIC
    • 19.6.1 BUSINESS OVERVIEW
    • 19.6.2 PRODUCT OFFERINGS
  • 19.7 BARDY DIAGNOSTICS
    • 19.7.1 BUSINESS OVERVIEW
    • 19.7.2 PRODUCT OFFERINGS
  • 19.8 CARDIOMO CARE
    • 19.8.1 BUSINESS OVERVIEW
    • 19.8.2 PRODUCT OFFERINGS
  • 19.9 CARDIOLOGS
    • 19.9.1 BUSINESS OVERVIEW
    • 19.9.2 PRODUCT OFFERINGS
  • 19.10 DRAGERWERK AG
    • 19.10.1 BUSINESS OVERVIEW
    • 19.10.2 PRODUCT OFFERINGS
  • 19.11 F. HOFFMANN-LA ROCHE
    • 19.11.1 BUSINESS OVERVIEW
    • 19.11.2 PRODUCT OFFERINGS
  • 19.12 GE HEALTHCARE
    • 19.12.1 BUSINESS OVERVIEW
    • 19.12.2 PRODUCT OFFERINGS
  • 19.13 GRANDCARE SYSTEMS
    • 19.13.1 BUSINESS OVERVIEW
    • 19.13.2 PRODUCT OFFERINGS
  • 19.14 HONEYWELL INTERNATIONAL
    • 19.14.1 BUSINESS OVERVIEW
    • 19.14.2 PRODUCT OFFERINGS
  • 19.15 IHEALTHUNIFIEDCARE
    • 19.15.1 BUSINESS OVERVIEW
    • 19.15.2 PRODUCT OFFERINGS
  • 19.16 QARDIO
    • 19.16.1 BUSINESS OVERVIEW
    • 19.16.2 PRODUCT OFFERING
  • 19.17 MEDM
    • 19.17.1 BUSINESS OVERVIEW
    • 19.17.2 PRODUCT OFFERING
  • 19.18 MASIMO CORPORATION
    • 19.18.1 BUSINESS OVERVIEW
    • 19.18.2 PRODUCT OFFERINGS
  • 19.19 MEDOPAD
    • 19.19.1 BUSINESS OVERVIEW
    • 19.19.2 PRODUCT OFFERINGS
  • 19.20 NIHON KOHDEN
    • 19.20.1 BUSINESS OVERVIEW
    • 19.20.2 PRODUCT OFFERINGS
  • 19.21 OMRON HEALTHCARE
    • 19.21.1 BUSINESS OVERVIEW
    • 19.21.2 PRODUCT OFFERINGS
  • 19.22 OSPLABS
    • 19.22.1 BUSINESS OVERVIEW
    • 19.22.2 PRODUCT OFFERINGS
  • 19.23 RESIDEO TECHNOLOGIES
    • 19.23.1 BUSINESS OVERVIEW
    • 19.23.2 .PRODUCT OFFERING
  • 19.24 SMITHS MEDICAL
    • 19.24.1 BUSINESS OVERVIEW
    • 19.24.2 .PRODUCT OFFERINGS
  • 19.25 SPACELABS HEALTHCARE
    • 19.25.1 BUSINESS OVERVIEW
    • 19.25.2 PRODUCT OFFERINGS
  • 19.26 SENSEONICS
    • 19.26.1 BUSINESS OVERVIEW
    • 19.26.2 PRODUCT OFFERINGS
  • 19.27 TELEMEDCARE
    • 19.27.1 BUSINESS OVERVIEW
    • 19.27.2 PRODUCT OFFERINGS
  • 19.28 VITALCONNECT
    • 19.28.1 PRODUCT OFFERINGS
  • 19.29 VITLS
    • 19.29.1 BUSINESS OVERVIEW
    • 19.29.2 PRODUCT OFFERINGS
  • 19.30 MODICARE
    • 19.30.1 BUSINESS OVERVIEW
    • 19.30.2 PRODUCT OFFERINGS
  • 19.31 HILLROM
    • 19.31.1 BUSINESS OVERVIEW
    • 19.31.2 PRODUCT OFFERINGS
  • 19.32 VIVIFY HEALTH
    • 19.32.1 BUSINESS OVERVIEW
    • 19.32.2 PRODUCT OFFERING
  • 19.33 ACL DIGITAL
    • 19.33.1 BUSINESS OVERVIEW
    • 19.33.2 PRODUCT OFFERINGS
  • 19.34 DEXCOM
    • 19.34.1 BUSINESS OVERVIEW
    • 19.34.2 PRODUCT OFFERING
  • 19.35 IRHYTHM TECHNOLOGIES
    • 19.35.1 BUSINESS OVERVIEW
    • 19.35.2 PRODUCT OFFERING
  • 19.36 VIVALINK
    • 19.36.1 BUSINESS OVERVIEW
    • 19.36.2 PRODUCT OFFERING
  • 19.37 BIOBEAT
    • 19.37.1 PRODUCT OFFERINGS
  • 19.38 CAREVALIDATE
    • 19.38.1 BUSINESS OVERVIEW
    • 19.38.2 PRODUCT OFFERINGS
  • 19.39 BIOFOURMIS
    • 19.39.1 BUSINESS OVERVIEW
    • 19.39.2 PRODUCT OFFERING
  • 19.40 CAREMINDR
    • 19.40.1 BUSINESS OVERVIEW
    • 19.40.2 PRODUCT OFFERING
  • 19.41 DATOS HEALTH
    • 19.41.1 BUSINESS OVERVIEW
    • 19.41.2 PRODUCT OFFERINGS

20 REPORT SUMMARY

  • 20.1 KEY TAKEAWAYS
  • 20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

  • 21.1 MARKET BY COMPONENTS
    • 21.1.1 MARKET BY DEVICES & SOFTWARE
    • 21.1.2 MARKET BY CARDIAC MONITORING DEVICES
    • 21.1.3 MARKET BY RESPIRATORY MONITORING DEVICES
  • 21.2 MARKET BY APPLICATION
  • 21.3 MARKET BY END USER

22 APPENDIX

  • 22.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF US REMOTE PATIENT MONITORING MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 IMPACT OF TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY & REMOTE MONITORING
  • EXHIBIT 4 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES FOR THE REMOTE MONITORING
  • EXHIBIT 5 IMPACT OF INCREASING ROLE OF INTERNET OF THINGS (IOT) FOR REMOTE MONITORING & HEALTHCARE
  • EXHIBIT 6 WAYS HEALTHCARE IOT & REMOTE PATIENT MONITORING ARE TRANSFORMING CARE DELIVERY
  • EXHIBIT 7 IMPACT OF INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES
  • EXHIBIT 8 IMPACT OF GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING
  • EXHIBIT 9 IMPACT OF AGING POPULATION VULNERABLE TO CHRONIC DISEASES
  • EXHIBIT 10 IMPACT OF GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
  • EXHIBIT 11 IMPACT OF REGULATORY VARIATIONS ACROSS COUNTRY
  • EXHIBIT 12 IMPACT OF LACK OF DATA ACCURACY
  • EXHIBIT 13 US REMOTE PATIENT MONITORING MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 14 US REMOTE PATIENT MONITORING MARKET BY COMPONENT
  • EXHIBIT 15 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE
  • EXHIBIT 16 US REMOTE PATIENT MONITORING MARKET BY APPLICATION
  • EXHIBIT 17 US REMOTE PATIENT MONITORING MARKET BY END-USER
  • EXHIBIT 18 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 19 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
  • EXHIBIT 20 INCREMENTAL GROWTH BY DEVICES & SOFTWARE 2021 & 2027
  • EXHIBIT 21 US REMOTE PATIENT MONITORING MARKET BY PRODUCT
  • EXHIBIT 22 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: INCREMENTAL GROWTH
  • EXHIBIT 23 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: ABSOLUTE GROWTH
  • EXHIBIT 24 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021-2027 ($ BILLION)
  • EXHIBIT 25 US REMOTE CARDIAC MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 26 US REMOTE CARDIAC MONITORING DEVICES MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 27 US ECG REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 28 US ECG REMOTE PATIENT MONITORING MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 29 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 30 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS 2021-2027 ($ BILLION)
  • EXHIBIT 31 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 32 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS 2021-2027 ($ BILLION)
  • EXHIBIT 33 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 34 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 35 US REMOTE RESPIRATORY MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 36 US REMOTE RESPIRATORY MONITORING DEVICES MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 37 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 38 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS 2021-2027 ($ BILLION)
  • EXHIBIT 39 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 40 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS 2021-2027 ($ BILLION)
  • EXHIBIT 41 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 42 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 43 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 44 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS 2021-2027 ($ BILLION)
  • EXHIBIT 45 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 46 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 47 US OTHER RPM DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 US OTHER RPM DEVICES MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 49 US REMOTE PATIENT MONITORING MARKET BY SERVICES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 50 US REMOTE PATIENT MONITORING MARKET BY SERVICES 2021-2027 ($ BILLION)
  • EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 52 US REMOTE PATIENT MONITORING MARKET BY APPLICATION
  • EXHIBIT 53 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH
  • EXHIBIT 54 US REMOTE CARDIOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 55 US REMOTE CARDIOLOGY PATIENT MONITORING 2021-2027 ($ BILLION)
  • EXHIBIT 56 US REMOTE PULMONOLOGY PATIENT MONITORING: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 57 US REMOTE PULMONOLOGY PATIENT MONITORING*MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 58 US REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 59 US REMOTE ENDOCRINOLOGY PATIENT MONITORING*MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 60 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 61 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 62 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 63 US REMOTE PATIENT MONITORING MARKET BY END-USER
  • EXHIBIT 64 US REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH
  • EXHIBIT 65 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 66 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS 2021-2027 ($ BILLION)
  • EXHIBIT 67 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 68 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS 2021-2027 ($ BILLION)
  • EXHIBIT 69 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 70 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS 2021-2027 ($ BILLION)
  • EXHIBIT 71 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 72 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS 2021-2027 ($ BILLION)
  • EXHIBIT 73 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 74 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS 2021-2027 ($ BILLION)
  • EXHIBIT 75 MEDTRONIC REVENUE 2018-2021 ($ BILLION)
  • EXHIBIT 76 MEDTRONIC SEGMENT 2021 (%)
  • EXHIBIT 77 PHILIPS HEALTHCARE SEGMENT 2021 (%)
  • EXHIBIT 78 PHILIPS HEALTHCARE REVENUE 2018-2021 ($ BILLION)
  • EXHIBIT 79 PHILIPS HEALTHCARE REGIONAL REVENUE 2021 (%)
  • EXHIBIT 80 RESMED REVENUE BY SEGMENT 2021 (%)
  • EXHIBIT 81 RESMED REVENUE 2018-2021 ($ BILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 MEDTRONIC: MAJOR PRODUCT OFFERINGS
  • TABLE 4 COVIDIEN PLC.: MAJOR PRODUCT OFFERINGS
  • TABLE 5 PHILIPS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 6 RESMED: MAJOR PRODUCT OFFERINGS
  • TABLE 7 100-PLUS: MAJOR PRODUCT OFFERINGS
  • TABLE 8 A&D COMPANY: MAJOR PRODUCT OFFERINGS
  • TABLE 9 ABBOTT: MAJOR PRODUCT OFFERINGS
  • TABLE 10 ALTUMVIEW SYSTEMS: MAJOR PRODUCT OFFERINGS
  • TABLE 11 BIOTRONIK: MAJOR PRODUCT OFFERINGS
  • TABLE 12 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 13 BARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 14 CARDIOMO CARE: MAJOR PRODUCT OFFERINGS
  • TABLE 15 CARDIOLOGS: MAJOR PRODUCT OFFERINGS
  • TABLE 16 DRAGERWERK AG: MAJOR PRODUCT OFFERINGS
  • TABLE 17 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS
  • TABLE 18 ROCHE DIABETES CARE. MAJOR PRODUCT OFFERINGS
  • TABLE 19 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 20 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS
  • TABLE 21 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS
  • TABLE 22 IHEALTHUNIFIEDCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 23 QARDIO: MAJOR PRODUCT OFFERINGS
  • TABLE 24 MEDM: MAJOR PRODUCT OFFERINGS
  • TABLE 25 MASIMO CORPORATION: MAJOR PRODUCT OFFERINGS
  • TABLE 26 MEDOPAD.: MAJOR PRODUCT OFFERINGS
  • TABLE 27 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS
  • TABLE 28 OMRON HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 29 OSPLABS: MAJOR PRODUCT OFFERINGS
  • TABLE 30 RESIDEO TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 31 SMITHS MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 32 SPACELABS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 33 SENSEONICS: MAJOR PRODUCT OFFERINGS
  • TABLE 34 TELEMEDCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 35 VITALCONNECT: MAJOR PRODUCT OFFERINGS
  • TABLE 36 VITLS: MAJOR PRODUCT OFFERINGS
  • TABLE 37 MODICARE: MAJOR PRODUCT OFFERINGS
  • TABLE 38 WELCH ALLYN: MAJOR PRODUCT OFFERINGS
  • TABLE 39 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 40 ACL DIGITAL: MAJOR PRODUCT OFFERINGS
  • TABLE 41 DEXCOM: MAJOR PRODUCT OFFERINGS
  • TABLE 42 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 43 VIVALINK: MAJOR PRODUCT OFFERINGS
  • TABLE 44 BIOBEAT: MAJOR PRODUCT OFFERINGS
  • TABLE 45 CAREVALIDATE: MAJOR PRODUCT OFFERINGS
  • TABLE 46 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
  • TABLE 47 CAREMINDR: MAJOR PRODUCT OFFERINGS
  • TABLE 48 DATOS HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 49 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021-2027 ($ BILLION)
  • TABLE 50 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021-2027 (%)
  • TABLE 51 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021-2027 ($ BILLION)
  • TABLE 52 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021-2027 (%)
  • TABLE 53 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021-2027 ($ BILLION)
  • TABLE 54 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021-2027 (%)
  • TABLE 55 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021-2027 ($ BILLION)
  • TABLE 56 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021-2027 (%)
  • TABLE 57 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021-2027 ($ BILLION)
  • TABLE 58 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 59 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021-2027 ($ BILLION)
  • TABLE 60 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021-2027 (%)